Taro Pharmaceutical Industries Ltd (NYSE:TARO)

145.59
Delayed Data
As of Apr 24
 -0.71 / -0.49%
Today’s Change
103.33
Today|||52-Week Range
173.00
-1.75%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues187.2M130.2M250.8M237.7M
 
 
 
 
 
Cost of Goods Sold41.7M40.9M48.7M40.3M
 
 
 
 
 
Depreciation And Amortization4.2M4.0M4.0M3.9M
 
 
 
 
 
 
Operating ExpensesGross Income141.4M85.4M198.1M193.5M
 
 
 
 
 
General Expenses39.8M37.4M35.5M34.2M
 
 
 
 
 
Research And Development13.2M15.0M13.8M12.8M
 
 
 
 
 
Total Operating Expenses85.6M82.2M88.3M78.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income101.5M48.0M162.6M159.3M
 
 
 
 
 
Extraordinary Credit--6.5M----
 
 
Extraordinary Charge-----2.3M--
 
 
Other Expenses4.3M-4.8M7.7M8.6M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income107.1M51.2M170.0M170.9M
 
 
 
 
 
Income Taxes-17.4M-4.9M-26.1M-28.2M
 
 
 
 
 
Minority Interest-81.0K-100.0K-319.0K-132.0K
 
 
 
 
 
Discontinued Operations-97.0K-124.0K-223.0K-126.0K
 
 
 
 
 
Net Income89.6M46.1M143.4M142.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS42.8M42.8M42.8M42.8M
 
 
 
 
 
Shares To Calculate EPS Diluted42.8M42.8M42.8M42.8M
 
 
 
 
 
 
Earnings Per ShareEPS$2.10$1.08$3.35$3.33
 
 
 
 
 
EPS Diluted$2.09$1.08$3.35$3.33
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account